Drug intelligence / Profile preview

tetracaine + oxybuprocaine

Development stage
Unknown
Lead developer
Alcon
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Colirofta Anestésico Doble is a fixed-dose combination ophthalmic solution containing two ester-type local anesthetics: tetracaine hydrochloride (0.1%) and oxybuprocaine hydrochloride (0.4%). It is primarily used in clinical ophthalmology to provide rapid, short-acting surface anesthesia of the cornea and conjunctiva. This anesthetic effect is essential for diagnostic procedures such as tonometry (measurement of intraocular pressure, critical for glaucoma monitoring), gonioscopy, and the removal of foreign bodies, as well as for minor surgical interventions. Both active ingredients act by reversibly blocking voltage-gated sodium channels on neuronal membranes, which inhibits the initiation and conduction of nerve impulses. The combination of two different anesthetics is intended to provide a more robust and reliable anesthetic effect for clinical practice. The product is widely used in Spanish healthcare settings, including the Hospital Universitario De Torrevieja, for routine ophthalmic examinations.

Brand names
Colirofta Anestésico Doble
Other names
Tetracaína + OxibuprocaínaTetracaine hydrochloride + Oxybuprocaine hydrochloride
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on tetracaine + oxybuprocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetracaine + oxybuprocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call